Search results for "Endocrine System"

showing 10 items of 1530 documents

Die Diagnostik des hilären Cholangiokarzinoms: Wertigkeit von präoperativer ERC, MRC und PTC im Vergleich zur Histopathologie

2005

PURPOSE To compare the results of the preoperative workup consisting of endoscopic retrograde cholangiography (ERC), magnetic resonance cholangiography (MRC), and percutaneous resonance cholangiography (PTC) with the tumor extent of the surgical specimen in patients with hilar cholangiocarcinoma (hilCC). MATERIALS AND METHODS Between 9/1997 and 12/2002, 59 patients with hilCC tumor underwent surgical resection. Preoperative ERC, MRC, and PTC were analyzed, blinded for the identity of the patient, and compared with the surgical specimen. For this retrospective analysis, 55 of the initial 59 ERCs, 39 of the initial 40 MRCs and 32 of the initial 38 PTCs were available. Most of the ERCs and MRC…

medicine.medical_specialtyPercutaneousendocrine system diseasesmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingCholangiographyMcNemar's testOncologyMedical imagingmedicineCurative surgeryRadiology Nuclear Medicine and imagingHistopathologyIn patientRadiologybusinessRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Experiences of a poison center with metformin-associated lactic acidosis.

2004

Metformin is widely used in the treatment of type 2 diabetes, though it is recognized to be associated with the risk of lactic acidosis. A case of pronounced lactic acidosis with cardiac arrest (pH 6.60, lactate 17.5 mmol/l, base excess - 30, standard bicarbonate 2.5 mmol/l, core body temperature 27.8 degrees C) is presented in a 61-year-old woman under metformin therapy. The key laboratory abnormalities observed during the intensive care treatment including repeated hemodialysis are described. The patient showed a complete recovery with residually reduced mental capabilities. Furthermore, an explorative data analysis of our poison center database from 1995 until 2003 concerning metformin w…

medicine.medical_specialtyPoison Control Centersendocrine system diseasesEndocrinology Diabetes and MetabolismPoison controlSuicide AttemptedType 2 diabetesGastroenterologyEndocrinologyInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsAcidosisbusiness.industryMetabolic disordernutritional and metabolic diseasesMetabolic acidosisGeneral MedicineMiddle Agedmedicine.diseaseMetforminSurgeryMetforminDiabetes Mellitus Type 2Lactic acidosisBase excessAcidosis LacticFemalemedicine.symptombusinessmedicine.drugExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins

2022

Dyslipidaemia in type 2 diabetes mellitus (T2DM), which increases cardiovascular risk, includes abnormal metabolism of low-density lipoproteins (LDL). Our group has recently shown that liraglutide increases LDL catabolism in patients with T2DM and that it reduces the expression of PCSK9 (a major inhibitor of LDL-receptor expression) in vitro and in mice. This prompted us to study the effect of liraglutide on plasma PCSK9 level in patients with T2DM.We studied prospectively 82 patients with T2DM (51 without statins, 31 with statins). Plasma PCSK9 and plasma lipids were measured before and six months after the initiation of a treatment with liraglutide at a dose of 1.2 mg/day.Plasma PCSK9 was…

medicine.medical_specialtyStatinendocrine system diseasesmedicine.drug_classEndocrinology Diabetes and MetabolismType 2 diabetesMiceEndocrinologyDiabetes mellitusInternal medicineInternal MedicinemedicineAnimalsHumansGlycated HemoglobinCatabolismbusiness.industryLiraglutidePCSK9nutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineMetabolismLiraglutidemedicine.diseaseEndocrinologyDiabetes Mellitus Type 2lipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsProprotein Convertase 9businessmedicine.drugDiabetes & Metabolism
researchProduct

Indications and contraindications of dental implants in medically compromised patients: update.

2013

The aim of this study was to review the current scientific literature in order to analyse the indications and contraindications of dental implants in medically compromised patients. A reference research was carried out on PubMed using the key words “implant” AND (oral OR dental) AND (systemic disease OR medically compromised), in articles published between 1993 and 2013. The inclusion criteria were the following: clinical studies in which, at least, 10 patients were treated, consensus articles, reviewed articles and meta-analysis performed in humans treated with dental implants, and which included the disease diagnosis. A total of 64 articles were found, from which 16 met the inclusion crit…

medicine.medical_specialtySystemic diseaseOsteoporosisMEDLINEOdontologíaDiseaseReviewRisk FactorsmedicineEndocrine systemHumansDiseaseGeneral DentistryContraindicationDental Implantsbusiness.industryContraindications:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryCiencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASSurgeryImplantbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Celiac disease and endocrine autoimmunity.

2015

<b><i>Background:</i></b> Celiac disease (CD) is a small-intestinal inflammatory disease that is triggered by the ingestion of the storage proteins (gluten) of wheat, barley and rye. <b><i>Key Messages:</i></b> Endocrine autoimmunity is prevalent in patients with CD and their relatives. The genes that predispose to endocrine autoimmune diseases, e.g. type 1 diabetes, autoimmune thyroid diseases, and Addison's disease, i.e. DR3-DQ2 and DR4-DQ8, are also the major genetic determinants of CD, which is the best understood HLA-linked disease. Thus, up to 30% of first-degree relatives both of patients with CD and/or endocrine autoimmunity are affect…

medicine.medical_specialtyTissue transglutaminaseAutoimmunityEndocrine SystemDiseasemedicine.disease_causeAutoantigensAutoimmunityImmune systemInternal medicinemedicineEndocrine systemHumanschemistry.chemical_classificationType 1 diabetesbiologybusiness.industryThyroidGastroenterologynutritional and metabolic diseasesGeneral Medicinemedicine.diseaseGlutenCeliac DiseaseEndocrinologymedicine.anatomical_structurechemistrybiology.proteinbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Multiple brown tumours of tertiary hyperparathyroidism in a renal transplant recipient: : a case report

2010

Tertiary Hyperparathyroidism (HPT) is an uncommon condition that affects patients with secondary HPT after a successful kidney transplant. Bone alterations are the main consequences of this endocrine condition, including the development of an osteolytic lesion called brown tumour. This paper reports an unusual case of multiple brown tumours located in the maxilla and mandible in a 58-year-old renal transplant recipient, with tertiary HPT. Incisional biopsies were performed and, in both samples, the histopathological diagnoses were giant cell lesions. Due to these diagnoses, the medical history of chronic renal failure, and high levels of serum calcium and PTH, lesions were diagnosed as mult…

medicine.medical_specialtyTotal parathyroidectomyBone NeoplasmsTertiary hyperparathyroidismOrgan transplantationNeoplasms Multiple PrimarymedicineEndocrine systemHumansMedical historyGeneral Dentistrybusiness.industryHyperparathyroidismMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Jaw NeoplasmsKidney TransplantationSurgeryOtorhinolaryngologyRenal transplantGiant cellMaxillaUNESCO::CIENCIAS MÉDICASSurgeryFemalebusiness
researchProduct

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche

2021

Objective: The aim of this study is to clarify, in girls with premature pubarche (PP), the influence of premature androgenization on the prevalence of polycystic ovary syndrome (PCOS). Design and patients: Ninety-nine PP girls, 63 who developed PCOS and 36 who did not develop PCOS, were retrospectively included. Clinical, anthropometric, and metabolic parameters were evaluated at the time of diagnosis of PP and after 10 years from menarche to find predictive factors of PCOS. Results: Young females with PP showed a PCOS prevalence of 64% and showed a higher prevalence of familial history of diabetes (P = 0.004) and a lower prevalence of underweight (P = 0.025) than PP-NO-PCOS. In addition, g…

medicine.medical_specialtyWaistendocrine system diseasesEndocrinology Diabetes and MetabolismDiseases of the endocrine glands. Clinical endocrinologySettore MED/13 - EndocrinologiahyperandrogenismEndocrinologyInsulin resistanceInternal medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineHyperandrogenism .insulin resistancebusiness.industryResearchHyperandrogenismdyslipidemianutritional and metabolic diseasesvisceral obesitymedicine.diseaseRC648-665Polycystic ovaryEndocrinologyMenarcheUnderweightmedicine.symptomprecocious menarchebusinessDyslipidemiaEndocrine Connections
researchProduct

Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diab…

2021

This study investigates the effects of dapagliflozin on the visceral adiposity index (VAI), lipid accumulation product (LAP), product of triglycerides and glucose (TyG) and triglycerides to HDL-cholesterol ratio (TG/HDL-C) in patients with type 2 diabetes mellitus (T2D). In this real-life study, dapaglifozin was added to metformin alone (group 1, no. 42) or insulin plus metformin (group 2, no. 58) in 100 T2D patients. In group 1, after 6 months of dapaglifozin addition, a significant decrease in BMI (p < 0.001), waist circumference (WC) (p < 0.001), systolic blood pressure (SBP) (p = 0.009), diastolic blood pressure (DBP) (p = 0.012), mean fasting blood glucose (FBG), post-breakfast glucose…

medicine.medical_specialtyWaistendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentnutritional and metabolic diseasesCorrectionmedicine.diseaseGastroenterologyMetforminnot applicablechemistry.chemical_compoundInsulin resistanceBlood pressurechemistryDiabetes mellitusInternal medicineInternal MedicinemedicineDapagliflozinbusinessLipid Accumulation Productmedicine.drugDiabetes Therapy
researchProduct

Vitellogenesis inhibition in Oncopeltus fasciatus females (Heteroptera: Lygaeidae) exposed to cadmium

2005

Abstract Newly moulted females of the insect Oncopeltus fasciatus were exposed to cadmium (Cd) dissolved in the drinking water (50–400 mg l −1 Cd) for 5 days. Cd exposure delayed ovarian maturation and inhibited egg production. Exposure to Cd, moreover, decreased hemolymph levels of the two major vitellogenin polypeptides of O. fasciatus , VG1 and VG2, in a concentration-dependent way, probably by a reduction in their synthesis. The ovarian levels of VG1 and VG2 were also decreased in Cd-exposed females. It was next investigated whether Cd effects might be a consequence of the endocrine disruption of vitellogenin synthesis, which is controlled by juvenile hormone (JH). JH replacement therap…

medicine.medical_specialtyanimal structuresPhysiologyFat Bodychemistry.chemical_elementHeteropteraVitellogeninsVitellogeninHemolymphInternal medicineHemolymphmedicineAnimalsEndocrine systemReceptorCadmiumDose-Response Relationship DrugbiologyReproductionOvaryVitellogenesisFeeding BehaviorJuvenile HormonesEndocrinologychemistryInsect ScienceJuvenile hormonebiology.proteinFemaleVitellogenesisFood DeprivationVitellogeninsCadmiumJournal of Insect Physiology
researchProduct

The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes

2019

Mitochondrial dysfunction has been shown to play a central role in the pathophysiology of type 2 diabetes (T2D), and mitochondria-targeted agents such as SS-31 are emerging as a promising strategy for its treatment. We aimed to study the effects of SS-31 on leukocytes from T2D patients by evaluating oxidative stress, endoplasmic reticulum (ER) stress and autophagy. Sixty-one T2D patients and 53 controls were included. Anthropometric and analytical measurements were performed. We also assessed reactive oxygen species (ROS) production, calcium content, the expression of ER stress markers GRP78, CHOP, P-eIF2&alpha

medicine.medical_specialtyautophagyendocrine system diseaseslcsh:MedicineCHOPMitochondrionmedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineoxidative stress030304 developmental biologychemistry.chemical_classification0303 health sciencesReactive oxygen speciesbusiness.industrySS-31Endoplasmic reticulumAutophagylcsh:Rnutritional and metabolic diseasesGeneral MedicineBECN1MitochondriaEndocrinologychemistry030220 oncology & carcinogenesisUnfolded protein responseendoplasmic reticulum stresstype 2 diabetesbusinessOxidative stressJournal of Clinical Medicine
researchProduct